+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Prosthetic Heart Valves Market 2019-2025

  • ID: 4863399
  • Report
  • September 2019
  • Region: Global
  • Orion Market Research Private Limited
UP TO OFF
until Mar 31st 2021
1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Abbott Laboratories Inc.
  • Boston Scientific Corp.
  • Braile Biomédica
  • Cardiosolutions, Inc.
  • Colibri Heart Valve LLC
  • CryoLife, Inc.
  • MORE
Global Prosthetic Heart Valves Market Size, Share & Trends Analysis Report by Type (Mechanical Heart Valves, Biological/Tissue Heart Valves, and Transcatheter Mitral Heart Valves) and by End-User (Hospitals and Ambulatory Centers) and Forecast 2019-2025.

The global prosthetic heart valve market is expected to grow significantly during the forecast period. It is an implanted device that finds its increasing adoption in patients suffering from valvular heart disease. The prosthetic heart valve is gaining momentum due to rising geriatric population and growing heart diseases. Through a cardiac surgery, a prosthetic heart valve enables to replace the abnormal heart valve market. Mechanical and bio-prostheses are the conventional methods of heart valve replacements. However, the replacement therapies are imperfect and subject patients to one or more ongoing risks, which hampers its acceptance in medical procedures across the globe.

Additionally, technical advancement and FDA clearance to critical heart valve market devices are driving the growth of the prosthetic heart valves market. The rising incidence and prevalence rate of valvular heart disease and the growing geriatric population across the globe, which is anticipated to boost the demand for innovative heart valve devices and applications. Technological progressions in the field of interventional cardiology that include transcatheter aortic valve replacement (TAVR) and the aspiration to omit the need for open surgical procedures for valve replacements will drive the market growth.

Geographically, the global prosthetic heart valves market is classified into North America, Europe, Asia-Pacific, and Rest of the World. North America is anticipated to have a significant share in the global prosthetic heart valves market due to the increasing THV processes coupled with the rising adoption of technologically advanced products. Moreover, Asia-Pacific is estimated to have considerable growth in the global market during the forecast period. The growth is owing to increasing awareness of heart-related diseases in emerging economies, such as China, Japan, and India with the growth in the number of hospitals in these countries.

The global prosthetic heart valves market is influenced by product development and advancements conducted by the market players. The key players of the global prosthetic heart valves market include Abbott Laboratories Inc., Boston Scientific Corp., Edwards Lifesciences Corp., LivaNova PLC, CryoLife, Inc., and Medtronic PLC. These players are playing a significant role in the growth of the prosthetic heart valves market by providing various products and adopting several strategies such as merger and acquisition, partnerships and collaboration, technological development, and others.

Research Methodology

The market study of the global prosthetic heart valves market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. the research team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analyst to derive the closest possible figures without any major deviations in the actual number. the analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports.

Secondary Sources Include
  • Financial reports of companies involved in the market
  • Whitepapers, research-papers, and news blogs
  • Company websites and their product catalog
The report is intended for a healthcare service provider, research institutes, and government organizations for overall market analysis and competitive analysis. The report provides an in-depth analysis of the market size and growth opportunities. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions.

Market Segmentation

1. Global Prosthetic Heart Valves Market Research and Analysis by Type
2. Global Prosthetic Heart Valves Market Research and Analysis by End-User

The Report Covers
  • Comprehensive research methodology of the global prosthetic heart valves market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global prosthetic heart valves market.
  • Insights about market determinants which are stimulating the global prosthetic heart valves market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Abbott Laboratories Inc.
  • Boston Scientific Corp.
  • Braile Biomédica
  • Cardiosolutions, Inc.
  • Colibri Heart Valve LLC
  • CryoLife, Inc.
  • MORE
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
1.2.3. By Stakeholders

2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations

3. Competitive Landscape
3.1. Company Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Abbott Laboratories Inc.
3.3.1.1. Overview
3.3.1.2. Financial Analysis
3.3.1.3. SWOT Analysis
3.3.1.4. Recent Developments
3.3.2. Boston Scientific Corp.
3.3.2.1. Overview
3.3.2.2. Financial Analysis
3.3.2.3. SWOT Analysis
3.3.2.4. Recent Developments
3.3.3. Edwards Lifesciences Corp.
3.3.3.1. Overview
3.3.3.2. Financial Analysis
3.3.3.3. SWOT Analysis
3.3.3.4. Recent Developments
3.3.4. LivaNova PLC
3.3.4.1. Overview
3.3.4.2. Financial Analysis
3.3.4.3. SWOT Analysis
3.3.4.4. Recent Developments
3.3.5. CryoLife, Inc.
3.3.5.1. Overview
3.3.5.2. Financial Analysis
3.3.5.3. SWOT Analysis
3.3.5.4. Recent Developments

4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities

5. Market Segmentation
5.1. Global Prosthetic Heart Valves Market by Type
5.1.1. Mechanical Heart Valves
5.1.2. Biological/Tissue Heart Valves
5.1.3. Transcatheter Mitral Heart Valves
5.2. Global Prosthetic Heart Valves Market by End-User
5.2.1. Hospitals
5.2.2. Ambulatory Centers

6. Regional Analysis
6.1. North America
6.1.1. United States
6.1.2. Canada
6.2. Europe
6.2.1. UK
6.2.2. Germany
6.2.3. Italy
6.2.4. Spain
6.2.5. France
6.2.6. Rest of Europe
6.3. Asia-Pacific
6.3.1. China
6.3.2. India
6.3.3. Japan
6.3.4. Rest of Asia-Pacific
6.4. Rest of the World

7. Company Profiles
7.1. Abbott Laboratories Inc.
7.2. Boston Scientific Corp.
7.3. Braile Biomédica
7.4. Cardiosolutions, Inc.
7.5. Colibri Heart Valve LLC
7.6. CryoLife, Inc.
7.7. Edwards Lifesciences Corp.
7.8. Hancock Jaffe Laboratories, Inc.
7.9. HLT, Inc.
7.10. JenaValve Technology, Inc.
7.11. Lepu Medical Technology Co., Ltd.
7.12. LivaNova PLC
7.13. Medtentia International Ltd Oy
7.14. Medtronic PLC
7.15. Micro Interventional Devices, Inc.
7.16. Novostia SA
7.17. The Charles Stark Draper Laboratory, Inc.
7.18. TTK Healthcare Ltd.
Note: Product cover images may vary from those shown
3 of 3
  • Abbott Laboratories Inc.
  • Boston Scientific Corp.
  • Braile Biomédica
  • Cardiosolutions, Inc.
  • Colibri Heart Valve LLC
  • CryoLife, Inc.
  • Edwards Lifesciences Corp.
  • Hancock Jaffe Laboratories, Inc.
  • HLT, Inc.
  • JenaValve Technology, Inc.
  • Lepu Medical Technology Co., Ltd.
  • LivaNova PLC
  • Medtentia International Ltd Oy
  • Medtronic PLC
  • Micro Interventional Devices, Inc.
  • Novostia SA
  • The Charles Stark Draper Laboratory, Inc.
  • TTK Healthcare Ltd.
Note: Product cover images may vary from those shown
Adroll
adroll